Table 3.
Summary of adverse effects (mean ± SD)
| Case | Creatinine at baseline (mg/dL) | eGFR at baseline (mL/min/1.73 m2) | Adverse effects (grade) | Onset time of grade 2 adverse effects |
| 1 | 1.19 | 45.6 | Elevated creatinine (3) | Week 2 |
| Anorexia (2) | Week 2 | |||
| 2 | 0.70 | 83.7 | Elevated creatinine (2) | Week 2 |
| Anorexia (2) | Week 3 | |||
| 3 | 1.00 | 56.9 | Elevated creatinine (2) | Week 3 |
| 4 | 0.75 | 80.2 | Elevated creatinine (2) | Week 3 |
| 5 | 0.63 | 70.2 | Elevated creatinine (2) | Week 4 |
| Anorexia (1) | ||||
| 6 | 0.43 | 111.5 | Anorexia (1) | |
| Elevated creatinine (1) |